Cookie Policy - To find out more about cookies on this website, see our privacy policy

Cookie Policy

We Help Companies Find New Sales Opportunities

We Help Companies Find New Sales Opportunities


Concateno, the drug and alcohol testing company with sites in Abingdon, London, Cardiff and Spain, is to be acquired by Inverness Medical Innovations in a £147m deal.

Concateno is to relocate its drugs testing business and up to 100 jobs from London and Warrington to Milton Park, near Didcot, by next May.

Concateno is to acquire Cozart, the Abingdon-based drug testing firm, for £64m, funded by a £54m share placing.

Concateno has acquired CPL International, the Liverpool-based provider of alcohol and drug testing services, for £0.8m.

Concateno is to acquire Marconova, the Swedish drug and alcohol testing company, for £2m.

Concateno has acquired Euromed, the London-based provider of drug testing devices with 13 staff, for £12m.

Concateno has acquired Medscreen, the London-based provider of drug and alcohol testing services with 49 staff in Canary Wharf, 60 UK collection officers and 260 overseas contractors, for £30m.